Florida Senate - 2021 COMMITTEE AMENDMENT Bill No. PCS (211898) for CS for SB 272 Ì381602vÎ381602 LEGISLATIVE ACTION Senate . House Comm: RCS . 03/11/2021 . . . . ————————————————————————————————————————————————————————————————— ————————————————————————————————————————————————————————————————— The Committee on Appropriations (Rouson) recommended the following: 1 Senate Amendment 2 3 Delete lines 34 - 72 4 and insert: 5 members: 6 (a) As appointed by the Governor: 7 1. A representative of the Department of Health. 8 2. A representative of the Agency for Health Care 9 Administration. 10 3. A representative of the Office of Insurance Regulation. 11 4. A representative of the Department of Education. 12 5. One geneticist practicing in this state. 13 6. One registered nurse or advanced practice registered 14 nurse who is licensed and practicing in this state with 15 experience in treating rare diseases. 16 7. One hospital administrator from a hospital in this state 17 which provides care to individuals diagnosed with rare diseases. 18 8. A pharmacist who is licensed and practicing in this 19 state who has experience with drugs that are used in the 20 treatment of rare diseases. 21 9. A representative of the biotechnology industry. 22 10. A representative of health insurance companies. 23 (b) As appointed by the President of the Senate: 24 1. A representative from an academic research institution 25 in this state which receives grant funding for research 26 regarding rare diseases. 27 2. A physician who is licensed under chapter 458 or chapter 28 459 and practicing in this state with experience in treating 29 rare diseases. 30 3. An individual who is 18 years of age or older who has a 31 rare disease. 32 4. An individual who is a caregiver of an individual with a 33 rare disease. 34 5. A representative of an organization operating in this 35 state which provides care or other support to individuals with 36 rare disease. 37 (c) As appointed by the Speaker of the House of 38 Representatives: 39 1. A representative from an academic research institution 40 in this state which receives grant funding for research 41 regarding rare disease. 42 2. A physician who is licensed under chapter 458 or chapter 43 459 and practicing in this state with experience in treating 44 rare diseases. 45 3. An individual who is 18 years of age or older who has a 46 rare disease. 47 4. An individual who is a caregiver of an individual with a 48 rare disease. 49 5. A representative of organizations in this state which 50 provide care or other support to individuals with rare diseases. 51 52 Any vacancy on the advisory council must be filled in the same 53 manner as the original appointment. 54 (3) The initial members of the advisory council must be 55 appointed by September 1, 2021. Each member must be appointed to 56 a 4-year term of office. However, in order to achieve staggered 57 terms, each of the initial members appointed pursuant to 58 paragraph (2)(a) must be appointed to a 2-year term. The